Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Orlando: Adding to ADDLs: Where Are They; What Might They Be Doing?
3 November 2002. As the amyloid pathology is shifting away from blaming predominantly amyloid plaques to now pointing a second accusing finger to smaller, non-deposited aggregates of the Aβ peptide, several labs are racing to show exactly what these small suspects might be doing, especially around synapses, and just how they might be toxic. For example, Bill Klein of Northwestern University in Chicago has a series of presentations here in Orlando on his lab’s attempt to take the existing data into the context of neurons and in vivo.

His group is extending their 1998 findings that small Aβ42 oligomers, which they call Aβ-derived diffusible ligands, or ADDLs, (see Lambert et al.) are neurotoxic. On Sunday here at the Neuroscience Conference, Kirsten Viola presented a poster suggesting that, on cultured rat embryonic neurons and human neural precursor cells, ADDLs bind specifically and form distinct little clusters. The authors call these dots "puncta," as clusters of synaptic proteins are frequently referred to. (The ADDL puncta did not colocalize with classic synaptic markers such as synaptophysin or the NGF receptor, however.)

At about a quarter of a micron in size, these dots are near the resolution limit of the light microscope, making further structural analysis in that way difficult. However, the clustering seems to fit with findings from Hilal Lashuel and Peter Lansbury that annealed, higher-order structures of Aβ oligomers can form ring-like structures in the electron microscope and their hypothesis that these might insert into neuronal membranes and form pathologic pores (see Lansbury interview).

Viola et al. saw the puncta on all cell surfaces but they appeared particularly dense along the neuron’s processes, including the neurite tips and growth cones. Further, immunocytochemistry, western blots, and immunoblots of membrane preparation from the cultured cells found that the ADDL puncta colocalized with phosphorylated FAK-YP, a protein previously linked to LTP and Aβ toxicity. The presence of ADDLs appeared to increase the number of FAK-YP puncta by about 100 sites per neurons. Finally, the poster reported that ADDLs appear to bind a novel toxin receptor, which remains unidentified.

Klein’s group will present three more posters on ADDLs on Wednesday, so watch this space for continued coverage by our guest writer, Brenda Patoine.

On the question of how ADDLs might pass their neurotoxic signal on inside the neuron, Lennart Mucke’s group also presented a poster yesterday that implicated more deeply the tyrosine kinase Fyn and its downstream pathways. The link had been made in brain slice experiments previously. Crossing human mutant APP-transgenic mice with Fyn knockout mice decreased the synaptic pathology that the scientists see in those Aβ-overproducing mice when Fyn is present.-Gabrielle Strobel.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad